Narrow search
Showing 1 - 10 of 1,574
Cover Image
Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico
Santiago-Rodriguez, Fernando; Dutrenit, Gabriela - United Nations University, Maastricht Economic and … - 2010
Interactive learning, particularly between firms and public research organizations (PRO), nurtures the dynamics of systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by developing countries. But why this is so? Based on...
Persistent link: https://www.econbiz.de/10008693155
Cover Image
Global Framework for Differential Pricing of Pharmaceuticals
Daems, Rutger; Maes, Edith; Ramani, Shyama V. - United Nations University-Maastricht Economic Research … - 2011
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
Cover Image
Study of logistics issues in the Indian pharmaceutical industry
Puri, Sandeep; Ranjan, Jayanthi - In: International Journal of Logistics Economics and … 4 (2012) 3, pp. 150-161
Indian pharmaceutical industry is one of the fastest growing sectors of Indian economy but the medicines we take suffer from serious ills: they are not stored and transported the way they ought to be. Pharmaceutical companies face issues related to choosing and working with the right logistics...
Persistent link: https://www.econbiz.de/10010668805
Cover Image
Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico
Santiago-Rodriguez, Fernando; Dutrenit, Gabriela - United Nations University-Maastricht Economic Research … - 2010
Interactive learning, particularly between firms and public research organizations (PRO), nurtures the dynamics of systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by developing countries. But why this is so? Based on...
Persistent link: https://www.econbiz.de/10010712332
Cover Image
Tendering and decision-making: a case on pharmaceutical products
Dankers, Sven; Vieira, Rui - In: World Review of Entrepreneurship, Management and … 8 (2012) 2, pp. 236-263
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising …
Persistent link: https://www.econbiz.de/10010670125
Cover Image
Discussion Note: Draft National Pharmaceutical Policy 2006
Network, All-India Drug Action - eSocialSciences - 2006
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
Cover Image
The Sectoral System of Innovation of Indian Pharmaceutical Industry
Mani, Sunil - eSocialSciences - 2008
The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the industry has three strong pillars: very pro active...
Persistent link: https://www.econbiz.de/10005699264
Cover Image
Pharmaceuticals, WTO/TRIPs and Women
Srinivasan, S - eSocialSciences - 2005
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276
Cover Image
Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?
de Frutos, Maria-Angeles; Ornaghi, Carmine; Siotis, Georges - C.E.P.R. Discussion Papers - 2010
We present a Hotelling model of price and advertising competition between prescription drugs that differ in quality …/side e¤ects. Advertising results in the endogenous formation of two consumer groups: brand loyal and non-brand loyal ones. We … show that advertising strategies are strategic substitutes, with the better quality drugs being the ones that are most …
Persistent link: https://www.econbiz.de/10008680762
Cover Image
Longitudinal Study on the Performance of U.S. Pharmaceutical Firms: The Increasing Role of Marketing
Pattikawa, L.H. - Erasmus Research Institute of Management (ERIM), … - 2007
pharmaceutical firms mainly focus on the role of R&D. In this paper, we investigate the impact of advertising and product …’ performance is not only closely linked to their R&D activities but also to marketing activities such as advertising and product … differentiation. Since the 1990s, the return of advertising has become three times larger than that of R&D. In addition, we found that …
Persistent link: https://www.econbiz.de/10010837584